[Skip to Content]
[Skip to Content Landing]
JAMA Diagnostic Test Interpretation
August 22/29, 2017

Screening for Depression

Author Affiliations
  • 1Department of Psychiatry, University of California-San Francisco
  • 2VA HRS&D Center for Health Information and Communication, Indianapolis, Indiana
  • 3Department of Medicine, Indiana University School of Medicine, and Regenstrief Institute Inc, Indianapolis
JAMA. 2017;318(8):745-746. doi:10.1001/jama.2017.9820

A 57-year-old man with a history of HIV disease, hyperlipidemia, and major depressive disorder presented to his primary care physician with depression and insomnia. His mood had been controlled with bupropion, 300 mg/d, for the past several years; however, the recent death of his husband led to increased hopelessness, insomnia, and decreased energy. Results of laboratory studies (thyroid-stimulating hormone, complete blood cell count, and metabolic profile) were unremarkable. His total score on the Patient Health Questionnaire 9 (PHQ-9) was 16 (Table 1).